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 Virus-specifi c CD8  T cells are central players in 
the fi ght against HIV, yet their sole presence, even 
in large numbers, is not directly correlated with 
better control of HIV replication. Indeed, increas-
ing evidence suggests that qualitative rather than 
quantitative aspects of CD8  T cell immunity 
provide the key to antiviral effi  cacy ( 1, 2 ). Despite 
intense eff orts, however, the precise attributes that 
confer certain CD8  T cell populations with an 
advantage in controlling HIV remain unclear; un-
derstanding these issues is necessary for the rational 
design of eff ective T cell – based vaccines. 
 Multiple factors, including immunologic, 
genetic, viral, and environmental, can potentially 
contribute to the rate of HIV disease progression 
in the absence of antiretroviral treatment. Further-
more, the virus-specifi c CD8  T cell response rep-
resents a constellation of constituent populations 
with respect to HLA restriction elements, targeted 
epitopes, and clonal diversity, even within a single 
infected individual. This profound heterogeneity 
hinders the accurate identifi cation of CD8  
T cell characteristics associated with protection. 
However, the study of  well-defi ned, more homo-
geneous CD8  T cell populations known to have 
a protective role in HIV infection might facilitate 
the search for such protective attributes. 
 The HLA class I molecules B∗2705 (B27) 
and B∗5701 (B57) are consistently linked with 
slower rates of HIV-1 disease progression, but 
the basis for these associations remains unclear 
( 3 – 5 ). Recent work suggests an active immuno-
domination of HLA-B27 – and HLA-B57 – re-
stricted CD8  T cell responses over other HLA 
allotypes ( 6 ); these two HLA molecules restrict 
  65% of the total HIV-1 – specifi c CD8  T cell 
response in individuals expressing these alleles ( 7 ). 
Remarkably, although HLA-B57 – restricted CD8  
T cell populations can present several HIV-
derived epitopes, the HLA-B27 – restricted CD8  
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 The key attributes of CD8  T cell protective immunity in human immunodefi ciency virus 
(HIV) infection remain unclear. We report that CD8  T cell responses specifi c for Gag and, 
in particular, the immunodominant p24 epitope KK10 correlate with control of HIV-1 
replication in human histocompatibility leukocyte antigen (HLA) – B27 patients. To under-
stand further the nature of CD8  T cell – mediated antiviral effi cacy, we performed a com-
prehensive study of CD8  T cells specifi c for the HLA-B27 – restricted epitope KK10 in 
chronic HIV-1 infection based on the use of multiparametric fl ow cytometry together with 
molecular clonotypic analysis and viral sequencing. We show that B27-KK10 – specifi c CD8  
T cells are characterized by polyfunctional capabilities, increased clonal turnover, and 
superior functional avidity. Such attributes are interlinked and constitute the basis for 
effective control of HIV-1 replication. These data on the features of effective CD8  T cells 
in HIV infection may aid in the development of successful T cell vaccines. 
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was held exclusively in p24 peptide pool 3, which also yielded 
the strongest responses compared with the other pools ( Fig. 
1 B ). Among all donors, HLA-B27 patients presented parti-
cularly strong responses to this pool ( Fig. 1 C ); the few non –
 HLA-B27 donors presenting reactivity to pool 3 were found 
to be HLA-B57. Pool 3 covers aa 221 – 275 of Gag and, there-
fore, includes the HLA-B27 – restricted immunodominant 
KK10 epitope (aa 263 – 272). To ensure that responses to pool 
3 in HLA-B27 donors were indeed targeted to KK10, pep-
tides from this pool were tested individually. Although pool 
3 – responding HLA-B57 donors targeted peptide 5 (which 
contains the previously identifi ed HLA-B57 epitope TW10), 
HLA-B27 donors targeted peptide 11 (aa 261 – 275), which 
indeed contains KK10 ( Fig. 1 D ). These observations illustrate 
the weight held by certain CD8  T cell populations (e.g., 
recognizing a single epitope) in associations between T cell 
responses and viral load. Together with the evidence from the 
literature (i.e., association between HLA-B∗2705 and pro-
longed AIDS-free survival, as well as the immunodominance 
of B27-KK10 – specifi c CD8  T cells with the p24 Gag-spe-
cifi c populations) (3–10), these data provide strong support for 
the protective role played by KK10-specifi c CD8  T cell re-
sponses in HLA-B27 donors and emphasize the importance of 
detailed analyses of this population to discover attributes asso-
ciated with its antiviral effi  cacy. 
 B27-KK10 – specifi c CD8  T cells display a 
polyfunctional profi le 
 Because of the development of recombinant MHC class I – pep-
tide complex technologies to identify HIV-specifi c CD8  T 
cells physically, several studies have sought to fi nd a relationship 
between the phenotype of such cells and their capacity to con-
trol viral replication. Skewed maturation, or the failure to reach 
advanced stages of diff erentiation (i.e., a CD45RA  /CD27  −  
phenotype), has been proposed as one reason for the inability of 
CD8  T cells to halt HIV disease progression ( 15, 16 ). Loss of 
IL-7 receptor (CD127) expression on virus-specifi c CD8  T 
cells has also been proposed to indicate cellular impairment in 
relation to persisting viral replication ( 17 ). In addition, recent 
reports have associated the expression of the inhibitory receptor 
programmed death – 1 (PD-1) on virus-specifi c CD8  T cells 
with failure to control HIV ( 18, 19 ). In this study, the compre-
hensive assessment of a large panel of markers associated with 
T cell diff erentiation (CD27, CD28, CC chemokine receptor 
[CCR] 7, and CD45RA), function (CD127, PD-1, and gran-
zyme B), and replicative senescence (CD57) using polychro-
matic fl ow cytometry revealed no signifi cant diff erences between 
protective B27-KK10 – specifi c CD8  T cells and CD8  T cells 
specifi c for other HIV epitopes from a series of 18 HIV-
infected donors ( Fig. 2, A and B ). In both cases, the majority of 
the cells displayed a typical intermediate diff erentiation pheno-
type (CD27  /CD28  −  /CD45RA  −  /CCR7  −  ) ( 20 ), with strong 
surface expression of PD-1, various levels of CD127 and CD57, 
and high intracellular levels of granzyme B. 
 Virus-specifi c CD8  T cells exert several eff ector func-
tions, mediated through the production of soluble factors and 
T cells in HIV-1 patients usually target one particular immuno-
dominant epitope in p24 Gag (residues 263 – 272), namely B27-
KK10 ( 7, 8 ). Furthermore, the emergence of escape mutations 
within this immunodominant epitope coincides with increased 
viral replication and progression to AIDS ( 9, 10 ); in contrast, 
HLA-B57 individuals are able to control the virus even after 
HIV has escaped from the dominant B57-restricted CD8  
T cell response ( 11 ). Although it remains to be formally demon-
strated, these data suggest that a single response to the immuno-
dominant B27-KK10 epitope may account for the association 
of HLA-B∗2705 with prolonged AIDS-free survival in HIV 
infection. Therefore, the study of B27-KK10 – restricted CD8  
T cell characteristics represents a unique opportunity to explore 
the basis for the protective nature of virus-specifi c CD8  T cells 
in HIV infection. 
 In this paper, we present a comprehensive study of B27-
KK10 – specifi c CD8  T cells in comparison with HIV-specifi c 
cells restricted by other HLA class I molecules in treatment-
naive HIV-infected slow or nonprogressors. For this purpose, 
we used multiparametric fl ow cytometry together with mo-
lecular clonotypic analysis to directly assess several attributes of 
HIV-specifi c CD8  T cell populations ex vivo. Specifi cally, 
we examined the phenotype (diff erentiation status and replica-
tive senescence), functional profi le (eff ector cytokine produc-
tion and degranulation), clonal diversity ( TCRB gene usage), 
and antigen sensitivity (functional avidity) of epitope-specifi c 
CD8  T cell populations. The data indicate a clear relationship 
between these parameters that distinguishes protective CD8  
T cell responses. 
 RESULTS 
 HLA-B27 – restricted Gag-specifi c CD8  T cells and superior 
control of HIV-1 replication 
 A recent population-based report has highlighted the stronger 
association of Gag-specifi c CD8  T cell responses — compared 
with other HIV protein – specifi c responses — with the control 
of HIV-1 replication ( 12 ). To address further the potential 
importance of Gag-specifi c CD8  T cells restricted through 
HLA-B27 in this association, whole Gag- or p24-specifi c 
CD8  T cell magnitude was assessed, and its correlation with 
cell-associated HIV – DNA viral load (cVL) was analyzed in a 
cohort of untreated slow progressors ( n  47), which includes 
11 HLA-B∗2705 donors. cVL represents the number of in-
fected cells harboring HIV-DNA, the direct targets of HIV-
specifi c CD8  T cells, and has been reported as a more 
sensitive marker of disease progression than plasma HIV – RNA 
load (pVL), at least once the viral setpoint is reached ( 13 ). As 
previously described ( 14 ), there was a modest but signifi cant 
inverse correlation between Gag-specifi c CD8  T cell num-
bers and cVL in these donors ( Fig. 1 A ). Interestingly, this 
inverse correlation became more signifi cant if considering 
exclusively HLA-B27 donors and was lost when HLA-B27 
donors were excluded from the analysis. The dissection of the 
total Gag-specifi c response according to the diff erent peptide 
pools covering the Gag sequence revealed that the association 
between CD8  T cell responses and cVL in HLA-B27 donors 
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polyfunctionality ( 22, 23 ). These fi ndings suggest that protective 
CD8  T cells are highly functional, which is in keeping with 
the maintenance of polyfunctional HIV-specifi c CD8  T cells 
in HIV-infected nonprogressors ( 21 ). 
 Clonal dominance and turnover in B27-KK10 – specifi c CD8  
T cell populations 
 HIV-specifi c CD8  T cell populations are generally oligo-
clonal ( 24 ), comprising several clonotypes specifi c for the 
same antigenic complex. The recognition properties and 
antiviral effi  cacy of such individual clonotypes, defi ned accord-
ing to their distinct TCR usage, can vary considerably. To in-
vestigate a potential impact for clonotype recruitment in 
diff erentiating the bulk properties of HIV-specifi c CD8  T cell 
populations, we performed a detailed molecular analysis of 
 TCRB gene expression ( 25, 26 ) within B27-KK10 – specifi c 
CD8  T cell populations in comparison with CD8  T cells 
specifi c for other HIV epitopes. Strikingly, we observed the 
consistent dominance of single clonotypes in all HIV-specifi c 
CD8  T cell populations ( Fig. 3 A and  Table I ). This ob-
servation held both for CD8  T cell populations specifi c 
for B27-KK10 and for those specifi c for other antigens. 
Moreover, there was no evidence for preferential usage of a 
particular CDR3 motif among the various B27-KK10 – spe-
cifi c CD8  T cell clonotypes (all  TCRB gene sequences are 
cytolytic mechanisms, to tackle virus dissemination. We there-
fore assessed the capacity of B27-KK10 – specifi c CD8  T cells 
to produce eff ector cytokines (IFN-  , TNF-  , macrophage 
infl ammatory protein [MIP] – 1  , and IL-2) and to release 
cytotoxic factors (up-regulation of CD107a together with 
degranulation of granzyme B) upon antigenic stimulation ( Fig. 
2 C ). On average, we observed that 70% ( ± 10% SE) of the 
diff erent antigen-specifi c CD8  T cell populations displayed 
at least one function. Recent data suggest that although the 
independent assessment of single functions may not be parti-
cularly informative, the simultaneous analysis of multiple para-
meters can provide a better picture of CD8  T cell functional 
quality ( 21 ). Surprisingly, B27-KK10 – specifi c CD8  T cells 
presented a superior multifunctional profi le in comparison 
with other HLA-restricted HIV-specifi c CD8  T cells ( Fig. 2 D ). 
In particular, they showed signifi cantly higher proportions of 
IFN-   /TNF-   /MIP-1   /CD107a  cells ( Fig. 2 E ). 
Detection of IL-2 production was very limited, even by B27-
KK10 – specifi c CD8  T cells. Remarkably, not only were 
B27-KK10 – specifi c CD8  T cells multifunctional, but they 
also produced more IFN-  on a per-cell basis than CD8  T 
cells specifi c for other HIV epitopes (as seen by measuring 
IFN-  median fl uorescence intensity (MFI;  Fig. 2 F ). This 
observation is consistent with recent studies showing an 
association between IFN-  MFI and the degree of T cell 
 Figure 1.  Association between Gag-specifi c CD8  T cell responses and viral load in HLA-B27 individuals. ( A) Total CD8  T cells responses spe-
cifi c for the Gag protein were assessed in IFN-  ELISPOT assays by stimulation with overlapping peptides of PBMCs from 47 antiretroviral therapy – naive 
HIV-infected donors, including 11 HLA-B27 donors. Magnitude (in SFU per 10 6 PBMCs) of responding cells specifi c for Gag was plotted as a function of 
cVL for all 47 donors, the 11 HLA-B27 donors, and the 36 non – HLA-B27 donors. Correlations were determined using the Spearman ‘ s rank test.  (B) Subdivi-
sion of Gag-specifi c responses from HLA-B27 donors according to peptide pools. Median responses for the 11 HLA-B27 donors are shown for each pool, 
and correlations between T cell frequencies and cVL were calculated.  (C) Frequency of T cells responding to p24 pool 3 in HLA-27 and non – HLA-B27 
donors. Horizontal bars represent means. The p-value was calculated by the Mann-Whitney U test. (D) Representative examples of HLA-B27 and HLA-B57 
donor responses to individual peptides ( n  11) included in p24 pool 3. Peptide 11 covers Gag residues 261 – 275. Gag-specifi c responses were assessed in 
duplicate, and CD8  T cell – depleted PBMCs were used to verify that observed responses were CD8  T cell mediated. 
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 Figure 2.  Phenotypic and functional assessment of B27-KK10 – specifi c CD8  T cells. ( A) Representative staining for the expression of cell 
 surface markers on B27-KK10 – specifi c CD8  T cells. HIV-specifi c cells identifi ed using MHC class I – peptide complexes (black) are superimposed on the 
whole CD8  T cell population in the same donor (red). Plots are gated on CD3  CD8  cells.  (B) Comparative marker expression between B27-KK10 – spe-
cifi c CD8  T cells (open diamonds) and other HIV-specifi c CD8  T cells (closed circles). Horizontal bars show medians. ( C) Representative example of 
simultaneous multifunctional assessment of B27-KK10 – specifi c CD8  T cells using nine-color fl ow cytometry. Cells were stimulated for 6 h in the pres-
ence of cognate peptide before intracellular staining. Percentages of cells in the different quadrants are shown. Plots are gated on CD3  CD8  cells. 
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with replicative senescence, i.e., shortening of telomere length 
and reduction of proliferative capacity ( 30, 31 ). This associa-
tion holds both when expressed on highly diff erentiated T cell 
subsets (i.e., the CD27  −  /CD28  −  compartment) and on less 
diff erentiated T cell subsets (i.e., the CD27  compartment 
that includes the majority of HIV-specifi c CD8  T cells; un-
published data). CD57 expression on T cells is therefore 
indicative of replicative history and provides information on 
earlier turnover. Dominant clonotypes within the HIV-spe-
cifi c CD8  T cell populations studied in this paper exhibit 
distinct  TCRBV gene usage ( Fig. 4 A and Table S1). Thus, the 
use of anti-TCRBV antibodies provided the means to identify 
dominant clonotypes within HIV-specifi c CD8  T cells by 
fl ow cytometry ( Fig. 4 B ) and assess the expression of CD57 in 
parallel ( Fig. 4 C ). The detection of both A2-SL9 – and B27-
KK10 – specifi c populations in patient 04.064 provides an in-
teresting example ( Fig. 4 D ). At the original time point, the 
dominant B27-KK10 clonotype (BV9) presented high levels 
of CD57 compared with both the subdominant B27-KK10 
clonotype (BV20.1) and the dominant A2-SL9 clonotype 
(BV5.1). At the later time point, the BV9 clonotype became 
subdominant within the B27-KK10 population, replaced by 
the BV20.1 clonotype that already showed increased levels of 
CD57. Expression of CD57 on the dominant A2-SL9 clono-
type remained low, and this clonotype persisted. In line with 
this observation, the overall analysis of TCRBV antibody –
 identifi ed B27-KK10 dominant clonotypes among the patients 
studied at two time points (i.e., from four patients) revealed a 
signifi cant increase in CD57 expression over time in relation 
to clonal turnover ( Fig. 4 E ). In contrast, no signifi cant changes 
in either CD57 expression or clonal turnover were observed 
for the other HIV-specifi c CD8  T cell populations (i.e., from 
fi ve patients). Interestingly, the B27-KK10 dominant clono-
types (identifi ed according to their TCRBV) from two donors 
lost their dominance upon peptide stimulation and in vitro 
expansion ( Fig. 4 F ). In the case of patient 04.064, we could 
even observe the preferential expansion of subdominant clono-
types (BV20.1) over the dominant one (BV9), which was in 
line with the ex vivo observations. Collectively, these data imply 
a decline of the replicative capacity for dominant B27 KK10 
clonotypes and suggest that T cell turnover may be related to 
replicative senescence at a clonal level. 
 Importance of a single dominant clonotype on HIV 
replication control 
 An irreversible loss of B27-KK10 – specifi c CD8  T cell – domi-
nant clonotypes, because of clonal senescence, is likely to aff ect 
shown in Table S1, available at http://www.jem.org/cgi/
content/full/jem.20070784/DC1). This observation suggests 
that the B27-KK10 complex can be recognized by diverse 
clonotypes with diff erent binding modalities ( 27 ) and argues 
against the consistent selection of a particular TCR that con-
fers exceptional properties. 
 We next wanted to assess the temporal pattern of clonal 
dominance. For this purpose, we analyzed historical cryopre-
served samples from seven HIV-infected donors ( Table II ), 
from which four B27-KK10 – specifi c CD8  T cell populations 
versus four CD8  T cell populations specifi c for other HIV ep-
itopes could be studied at two diff erent time points. A remark-
able dichotomy was observed. Although the clonal dominance 
of CD8  T cells specifi c for non – B27-KK10 epitopes did not 
alter over time ( Fig. 3 B ), the dominant clonotype in the B27-
KK10 – specifi c CD8  T cell populations changed consistently 
in all four matched donors ( Fig. 3 C ); these diff erential dynam-
ics occurred despite relatively limited variations in the magni-
tude of the respective HIV-specifi c T cell populations. These 
data suggest that B27-KK10 – specifi c CD8  T cell populations 
are characterized by a higher rate of clonal turnover compared 
with other HIV-specifi c CD8  T cell populations. 
 Relationship between clonal turnover and clonal senescence 
 Changes in clonal dominance may have two independent 
reasons: (a) the adaptation of B27-KK10 – specifi c CD8  T 
cell populations to viral variation ( 25 ), or (b) the replacement 
of clonotypes that approach replicative senescence. To ex-
plore the fi rst possibility, global sequencing of the Gag gene 
was undertaken at both time points ( Table II ). In two HLA-
B27 patients, viral variations could be seen in the KK10 epit-
ope. In 04.034, an M268L mutation occurred that might 
account for a change in clonal dominance. In 04.064, an 
N271Q variation in KK10 was observed that, although con-
fi ned to the C-terminal region of the epitope, might also 
 aff ect TCR interaction (because the penultimate epitope 
peptide side chain appears to point out of the groove) ( 28 ). 
However, in two other HLA-B27 patients (05.005 and 11.007), 
we observed no changes in the KK10 epitope. The overall 
dataset indicated that viral variation could not be the universal 
cause for clonal turnover, which is consistent with earlier 
observations in primary HIV-1 infection ( 29 ). 
 To examine the alternative option that clonal turnover 
may relate to the replacement of clonotypes that approach rep-
licative senescence, we assessed the expression of CD57 on 
dominant CD8  T cell clonotypes directly ex vivo. CD57 ex-
pression is linked to the appearance of characteristics associated 
 (D) The pie charts depict the background-adjusted multifunctional behavior (one to fi ve functions: CD107a, IFN-  , TNF-  , IL-2, and MIP-1  ) of B27-KK10 –
 specifi c CD8  T cell populations ( n  8) versus other HIV-specifi c CD8  T cell populations ( n  7, including 2xA3-RY10, 2xB7-GL9, and 3xA2-SL9). For 
simplicity, responses are grouped by the number of functions (indicated by the numbers inside the pie charts and matched to the colored bars in E). The 
p-value was calculated by the permutation test.  (E) Detailed functional responsiveness was analyzed for the B27-KK10 – specifi c CD8  T cell populations 
compared with the other HIV-specifi c CD8  T cell populations. Each bar shows the mean percentages of cells displaying a particular combination of 
functions within the total of functional cells. p-values were calculated by the Mann-Whitney U test.  (F) IFN-  fl uorescence of B27-KK10 – specifi c CD8  
T cells and other HIV-specifi c CD8  T cells upon stimulation with cognate peptides. Representative profi les are shown (left), and the IFN-  MFI ratios 
(for antigen-specifi c CD8  T cells upon stimulation/no activation) are presented for all populations studied (right). Horizontal bars represent means. 
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control of HIV replication. However, this remains a particu-
larly diffi  cult issue to address; because HIV-specifi c CD8  T 
cell clonotypes approaching senescence can be replaced by new 
clonotypes from the pool of naive precursors, the assessment of 
markers like CD57 at a given time point off ers no reliable in-
formation to predict the outcome for HIV control. We identi-
fi ed one HLA-B27 long-term survivor (02.011) who started 
progressing from one year ( 1 ) to another ( 2 ), as indicated by a 
rise in pVL together with a reduction in the magnitude of the 
B27-KK10 population and an ensuing drop in CD4  T cell 
counts ( Fig. 5 A ). Loss of control of HIV replication was associ-
ated with a near-to-complete disappearance of the dominant 
B27-KK10 clonotype present before progression ( Fig. 5 B ). 
However, the B27-KK10 – specifi c CD8  T cell population at 
this time point expressed modest CD57 levels in comparison 
with declining clonotypes from other donors ( Fig. 5 C ). In-
stead, it appears that the demise of this clonotype was caused by 
loss of antigenic stimulus or neglect: sequencing of the cognate 
viral epitope revealed the rapid emergence of a variant bearing 
the R264K mutation ( Fig. 5 D ), which is known to cause de-
fective binding to MHC class I and the loss of B27-KK10 – spe-
cifi c CD8  T cells associated with HIV disease progression 
( 9, 10, 28, 32 ). The emergence of the R264K escape virus 
resulted in the failure to stimulate B27-KK10 – specifi c CD8  
T cells (as seen with the reduced expression of the activation 
marker CD38 on the cell surface;  Fig. 5 E ) and the deletion of 
the dominant B27-KK10 – specifi c CD8  T cell clonotype, fol-
lowed by uncontrolled viral replication. Importantly, loss of 
immune control occurred despite the presence at the same time 
(year 2) of at least three subdominant HIV-specifi c CD8  T 
cell populations (all HLA-B7 restricted; specifi c for Gag 353 –
 363, Env 843 – 851, and Nef 128 – 137) detected by IFN-  
ELISPOT (unpublished data). Although clonal turnover and 
senescence are not implicated here, this case is interesting in 
that it illustrates the importance of maintaining the activity of 
protective CD8  T cell clonotypes in HIV infection: if the 
control exerted by such clonotypes is lost (because of viral escape 
as in the present example, or in the hypothetical case of clonal 
senescence in absence of renewal), uncontrolled viral replication 
can rapidly ensue in the face of persisting subdominant responses 
which are apparently unable to compensate. 
 Higher functional avidity and superior control 
of HIV replication 
 Increased T cell turnover is likely to be caused by a high level 
of antigenic exposure in relation to the quantity of antigen 
presented and/or the quality of the stimulus. The quantity of 
presented antigen may vary according to expression diff erences 
 Figure 3.  High turnover of B27-KK10 – specifi c CD8  T cell clono-
types. ( A) Clonal composition of several CD8  T cell populations specifi c 
for B27-KK10 or other epitopes. Clonotypic analysis was performed on 
FACS-sorted viable HIV-specifi c CD8  T cells. The percent frequencies of 
single clonotypes within B27-KK10 or other HIV epitope – specifi c CD8  
T cell populations are shown; each bar represents one population from one 
donor and is subdivided into distinct clonotypes represented according to 
frequency. 6 B27-KK10 and 9 out of 13 other HIV epitope – specifi c CD8  
T cell populations are shown. Donor identifi cation is provided under the bars, 
and a detailed clonotypic analysis (with sequences) is shown in  Table I 
and Table S1. (B and  C) Analysis of clonal dominance over two time 
points. The percent frequencies of HIV-specifi c CD8  T cells, identifi ed by 
cognate MHC class I – peptide multimeric complexes, within the total CD8  
population and clonal composition, represented as the frequency of indi-
vidual clonotypes within sorted HIV-specifi c CD8  T cell populations, are 
shown for four B27-KK10 ( C ) and four other HIV peptide – specifi c CD8  
T cell populations ( B ) separated by the indicated intervals. Donor identifi ca-
tion and specifi c responses are indicated; a detailed clonotypic analysis 
with sequences is shown in Table S1. 
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 Table I.  Clonal analysis of HIV-specifi c CD8   T cell populations 
 BV usage, CD3 aa sequence, BJ usage, and percent frequency for 6 B27-KK10 and 9 out of 13 other HIV epitope – specifi c CD8  T cell populations. The entire set of data is 
shown in Table S1. 
between the individual targeted HIV proteins ( 33 ). However, 
we observed diff erences in longitudinal clonal dominance pat-
terns between CD8  T cell populations specifi c for epitopes 
derived from the same protein (i.e., Gag); thus, an eff ect related 
to the quantity of presented antigen seems less likely. Alterna-
tively, the quality of antigenic stimulation might diff er between 
individual CD8  T cell populations and could be related to the 
avidity of cognate antigen engagement on the cell surface. 
We therefore assessed the relative functional avidity of HIV-
specifi c CD8  T cell populations directly ex vivo, using serial 
peptide concentrations and defi ning EC 50 as the exogenous 
peptide concentration yielding half-maximal counts in IFN-  
 Table II.  Patient characteristics and viral sequences 
Clinical characteristics of HIV-1 – infected patients and dominant (i.e.,   80%) HIV-1 epitope sequences for which cognate HIV-specifi c CD8  T cell responses were studied by 
clonotypic analysis at two time points. NA, nonavailable.
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tested populations. This fi nding underlines the central infl u-
ence of CD8  T cell functional avidity on the control of HIV 
replication. Remarkably, when considering the immunodom-
inant HIV-specifi c CD8  T cell responses (identifi ed through 
the screening of 49 CTL epitopes), we found an inverse cor-
relation between their functional avidity and the patients ’ cVL 
( Fig. 6 C ). The use of a limited number of CD8  T cell epit-
opes makes it possible that some immunodominant responses 
were not detected; this could explain why some populations 
exhibited low functional avidities in the context of low cVL. 
Although it did not reach statistical signifi cance, there was also 
a trend toward an inverse correlation between functional 
avidity and cVL when looking at highest subdominant responses. 
Interestingly, we could detect among these responses a sub-
dominant B27-KK10 CD8  T cell population, which showed 
a lower functional avidity (compared with immudominant 
B27-KK10 CD8  T cell populations) and was actually associ-
ated with a higher cVL in this donor ( Fig. 6 C , open circle). 
The observed correlation with avidity was stronger for cVL 
compared with pVL or CD4  T cell count, consistent with a 
higher sensitivity of cVL as a marker of disease progression 
( 13, 14 ). Overall, these observations suggest that the functional 
avidity of HIV-specifi c CD8  T cells is directly related to their 
capacity to control HIV replication through the elimination 
of infected cells. 
 DISCUSSION 
 The identifi cation of CD8  T cell correlates of immune con-
trol in HIV infection has remained an elusive yet profoundly 
important goal that will immeasurably advance our quest for 
an eff ective vaccine. However, the heterogeneity that exists 
between individuals and between CD8  T cell populations 
represents a major barrier to the precise identifi cation of these 
attributes. To understand the mechanistic basis of the immune 
protection mediated by CD8  T cells, we conducted a com-
prehensive study of CD8  T cell populations specifi c for B27-
KK10 that seem to confer favorable outcomes in infected 
individuals, as indicated by the literature and our data showing 
an inverse correlation between the magnitude of p24-specifi c 
CD8  T cell responses and cVL. We found that B27-KK10 –
 specifi c CD8  T cells exhibited a more polyfunctional profi le, 
demonstrated increased rates of clonal turnover associated with 
characteristics of senescence, and displayed superior functional 
avidity when compared with other HIV-specifi c CD8  T 
cells. These features are interlinked and characterize protective 
CD8  T cell – mediated immunity. 
 Polyfunctional capacity, or the ability to produce high 
levels of several soluble factors simultaneously, is emerging as 
a key factor of T cell eff ectiveness. Soluble factors secreted by 
T cells like cytokines, cytotoxins, or chemokines are central 
to the immune response, exerting direct eff ector capacities, 
or enabling further T cell recruitment or expansion. Two re-
cent studies indicate that vaccine effi  cacy depends on the in-
duction of polyfunctional T cells in both mice and humans 
( 22, 23 ). Our data suggest that CD8  T cells that achieve op-
timal control of HIV-1 replication also display polyfunctional 
ELISPOT assays ( Fig. 6 A ). A signifi cantly higher functional 
avidity of HLA-B – restricted responses over HLA-A – restricted 
responses was observed ( Fig. 6 B ); this dichotomy was driven, 
at least in part, by the preponderance of the B27-KK10 re-
sponses, which strikingly exhibited the highest avidity of all 
 Figure 4.  Changes in CD57 expression on B27-KK10 – specifi c 
CD8  T cell clonotypes. ( A) Clonal analysis (including TCRBV usage, 
CDR3 aa sequence, TCRBJ usage, and percent frequency) of the B27-
KK10 – and A2-SL9 – specifi c CD8  T cell populations present in patient 
04.064 at two time points (representing a total of 292  TCRB sequences). 
Representative examples of B27-KK10 pentamer and anti-TCRBV costain-
ing on CD8  T cells ( B ), and of anti-TCRBV and CD57 costaining on B27-
KK10 – gated CD8  T cells (patient 04.064, year 5; C) are shown. Numbers 
represent percentages of CD57  cells within the BV  /pentamer  popula-
tions. ( D) CD57 expression on TCRBV  B27-KK10 – or A2-SL9 – specifi c 
CD8  T cell populations for patient 04.064. ( E) CD57 expression on 
TCRBV  B27-KK10 – or other HIV-specifi c CD8  T cell populations for the 
seven patients studied. Clonotypes that are dominant at one of the two 
time points (for B27-KK10) or the two time points (for the other) are 
 presented; the arrows indicate the time of dominance. The p-value was 
calculated by the paired  t test. ( F) The percent frequency of B27-KK10 –
 specifi c CD8  T cells and the expression of TCRBV-characterizing domi-
nant clonotypes before (Pre) or after (Post) 9 d of in vitro expansion in the 
presence of KK10 peptide and IL-2. 
 o
n
 April 27, 2016
jem.rupress.org
D
ow
nloaded from
 
Published September 24, 2007
JEM VOL. 204, October 1, 2007 
ARTICLE
2481
HIV-1 infection ( 38 ), as well as with studies showing that 
immunodominant clonotypes have higher avidities compared 
with subdominant clonotypes in chronic CMV and EBV in-
fections ( 39, 40 ). Thus, among the diversity of HIV-specifi c 
CD8  T cells, it seems that those clonotypes that exhibit high 
levels of functional avidity will become immunodominant, 
presumably through competitive eff ects, and display superior 
functionality, thereby orchestrating more eff ective control of 
HIV replication. 
 However, high functional avidity also implies a stronger 
exposure of the cognate CD8  T cells to activation signals 
derived from a given concentration of antigen. This eff ect will 
result in proportionately greater levels of CD8  T cell stimu-
lation and proliferation, thereby causing the increased rate of 
clonal turnover within B27-KK10 – specifi c CD8  T cell pop-
ulations. However, CD8  T cells, like any other immune cells, 
have a limited replicative lifespan in vivo ( 41 ). This implies 
that they can be driven toward replicative senescence over time 
with sustained activation and proliferation, as suggested both 
by our observations with B27-KK10 – specifi c CD8  T cell 
populations at the clonal level and in other persistent viral 
infections ( 39 ). Mathematical modeling has highlighted the 
potential role for cellular senescence in shaping the CD8  T 
cell response to a persistent infection ( 42 ). Similarly, the inca-
pacity of immunodominant HIV-specifi c CD8  T cell popu-
lations to proliferate has been associated with progressive HIV 
disease ( 43 ). Our fi ndings are also in line with work in mouse 
models showing that persisting lymphocytic choriomeningitis 
capacities, in keeping with the original work from Betts et al. 
showing the maintenance of polyfunctional CD8  T cells in 
long-term nonprogressors ( 21 ). Collectively, these data pro-
vide further support for the consideration of T cell polyfunc-
tionality as a correlate of protective immunity. 
 Functional avidity, as defi ned in this paper, is a measure 
of the effi  ciency of antigen recognition by CD8  T cells. In 
previous reports, high avidity CD8  T cells have been shown 
to initiate the lysis of target cells more rapidly at any given 
antigen density and to be more eff ective at mediating viral 
clearance than low avidity cells ( 34 – 36 ). Thus, the effi  ciency 
with which CD8  T cells are stimulated and exert their anti-
viral eff ects to eradicate HIV-infected cells is dependent on 
functional avidity. In addition, recent work in mouse models 
suggests a correlation between T cell functionality and avid-
ity, so that the quality of the CD8  T cell response in terms 
of cytokine profi le is enhanced for highly avid T cells ( 37 ). 
Our results are in line with these fi ndings. The superior poly-
functionality of B27-KK10 – specifi c CD8  T cell populations 
may therefore directly relate to their higher functional avid-
ity, and these two features together may enable the more 
 effi  cient eradication of HIV-infected cells. The high avidity 
of B27-KK10 – specifi c CD8  T cell populations may also 
explain the general immunodominance of this response over 
other populations and its importance in bearing the brunt of the 
immunological impact of HIV replication. This is in keeping 
with recent work suggesting a correlation between func-
tional avidity and the magnitude of CD8  T cell responses in 
 Figure 5.  Disappearance of one B27-KK10 – specifi c CD8  T cell clonotype and loss of control of HIV replication.  (A) 5-yr follow-up (pVL, CD4 
counts, and percent frequency of B27-KK10 – specifi c CD8  T cells) in one patient (02.011) with sudden disease progression at year 2.  (B) Clonal analysis 
(TCRBV usage, CDR3 aa sequence, TCRBJ usage, and percent frequency) of B27-KK10 – specifi c CD8  T cell populations is shown for years 1 and 2 (represent-
ing a total of 150  TCRB sequences).  (C) CD57 expression on B27-KK10 – specifi c CD8  T cells. Percentages of pentamer  cells that express CD57 are indicated. 
 (D) KK10 viral sequence of the dominant (i.e.,   80%) HIV-1 strain over time.  (E) CD38 expression on B27-KK10 – specifi c CD8  T cells at years 1 and 2. 
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advanced stages of the infection, their thymic output and the 
number of naive cells decline considerably ( 47, 48 ), which 
will aff ect their ability to renew senescent clones with high 
turnover, resulting in suboptimal control of HIV replication 
despite the presence of subdominant HIV-specifi c CD8  T 
cell populations with lower rates of clonal turnover. Our work 
emphasizes the importance of studying clonal dynamics in the 
interpretation of cellular immune data. Although much work 
has concentrated on fi nding immunologic correlates of pro-
tection through the assessment of phenotypic markers on 
HIV-specifi c CD8  T cells at a given time point, our study 
indicates that this is unlikely to have any predictive value re-
garding the outcome for viral control, because new clonotypes 
with diff erent characteristics may be generated thereafter. 
The capacity to renew important clonotypes will be funda-
mental for the outcome of HIV-1 infection. 
 The identifi cation of functional avidity as a central feature 
of the protective nature and life span of CD8  T cells raises a 
question as to which factors determine the recruitment of 
high avidity clonotypes into any given antigen-specifi c CD8  
T cell population. Many variables, such as TCR avidity and 
density, CD8 coreceptor-mediated eff ects, membrane fl exi-
bility, and molecular topography can contribute to the over-
all functional avidity of a CD8  T cell population. The study 
of B27-KK10 – specifi c CD8  T cell clonotypes described in 
this paper hints at another potential determinant. Specifi cally, 
we observed a high degree of clonotypic diversity at the level 
of primary sequence across the CDR loops when compared, 
for example, with A2-SL9 – or B7-GL9 – specifi c CD8  T cell 
populations. One could speculate that a high degree of TCR 
diversity within antigen-experienced T cells provides the foun-
dation to establish high avidity populations, as clonotypes with 
highly avid TCRs may arise more easily from such a large 
source of possibilities. Further work is necessary to clarify the 
potential relationship between functional avidity and TCR 
diversity, and to reveal new insights into the genetic, bio-
physical, and structural bases of these eff ects. 
 In conclusion, the comprehensive analysis of a unique 
CD8  T cell population, known to mediate superior control 
of HIV-1 replication, enabled the identifi cation of distinct 
attributes that characterize the protective immunity medi-
ated by these cells. These fi ndings represent a substantial 
step forward in our understanding of several allied immune 
phenomena and illuminate the biological basis of CD8  T 
cell effi  cacy in HIV infection with associated implications 
for the evaluation of potential vaccine immunogens. 
 MATERIALS AND METHODS 
 Patients.  Samples were obtained from HIV-1 – infected patients enrolled in the 
French Agence Nationale de la Recherche sur le Sida (ANRS) ALT ( 4 ) and 
IMMUNOCO ( 49 ) cohorts. Antiretroviral therapy – naive patients during the 
chronic phase of infection — with CD4 counts   400 cells per cubic millimeter, 
no clinical symptoms, and pVL ranging from 200 to 3.5   10 5 copies of HIV-1 
RNA per milliliter — were selected for the study. The study was approved 
by the relevant local institutional (at the H ô pital Piti é -Salp ê tri è re) review 
board and ethics committee. PBMCs were separated from citrate anticoagu-
lated blood and cryopreserved for subsequent studies. HLA genotyping 
infection can lead to the disappearance of clonotypes with a 
near complete switch in the epitope-specifi c repertoire between 
acute and chronic infection ( 44 ), and that high dose antigen 
can be accompanied by the emergence of low avidity clono-
types ( 45 ). Collectively, this suggests that functional avidity can 
drive clonal turnover and senescence, and entails the need for 
continuous renewal of high avidity T cell clonotypes to maintain 
optimal control of HIV replication. 
 Although the case of patient 02.011 did not involve clonal 
senescence but loss of antigenic stimulation caused by viral 
escape, it off ers an interesting illustration of the disastrous 
consequences that the irreversible disappearance of dominant 
CD8  T cell clonotypes can have on the control of HIV rep-
lication. Constant output from the pool of naive T cell pre-
cursors is therefore a prerequisite to maintain an eff ective 
control of viral replication, to either replace important but 
senescent clonotypes or adapt the response to viral variations 
when possible. Recent data from the mouse models of persis-
tent viral infection indicate that new naive cells are continu-
ously being recruited during the chronic phase and that lack 
of thymic output results in the decline of virus-specifi c CD8  
T cells ( 46 ). However, as HIV-infected individuals reach 
 Figure 6.  CD8  T cell functional avidity and control of viral repli-
cation. ( A) Representative example of peptide titrations in IFN-  ELISPOT 
assays (normalized SFC per 10 6 PBMCs) to assess functional avidity of 
KK10 or other HIV epitope – specifi c CD8  T cells. Functional avidity is de-
fi ned as the concentration required to achieve half-maximal recognition 
of the wild-type peptide (EC 50 ). Error bar values are 95% confi dence in-
tervals.  (B) Functional avidity of CD8  T cell populations specifi c for HLA-
A – restricted (including 2, 3, 11, 26, and 31) or HLA-B – restricted (including 
7, 8, 27, 35, and 51) HIV epitopes ( n  20), as well as for B27-KK10. Hori-
zontal bars represent means. p-values were calculated by the Mann-
Whitney U test. (C) Correlation between functional avidity of immuno-
dominant HIV-specifi c CD8  T cell responses and HIV cVL. Immuno-
dominant ( n  16, closed symbols) and the highest subdominant 
( n  12, open symbols) responses are shown, as is a linear regression trend 
line. p-values and r values between cVL, pVL, CD4 count, and functional 
avidity are shown for the immunodominant responses. Spearman ‘ s rank 
test was used to determine correlations. 
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Percent frequencies of multifunctional cells were calculated within the total 
population of detectable antigen-specifi c CD8  T cells. 
 Cell stimulation for multifunctional assessment or in vitro expan-
sion.  Purifi ed PBMCs were thawed and rested overnight at 37 ° C in complete 
RPMI media (RPMI 1640 supplemented with 10% heat-inactivated fetal calf 
serum, l- glutamine, and antibiotics); viability was then examined by Trypan 
blue exclusion (typically  	 70% viable). For stimulation, at least 10 6 pentamer/
tetramer prestained cells were incubated in the presence of 5  μ M of specifi c 
peptide and 10  μ l of anti-CD107a antibodies for 1 h at 37 ° C in a 5% CO2 
incubator, followed by an additional 5 h in the presence of the secretion 
inhi bitors monensin (2.5  μ g/ml; Sigma-Aldrich) and Brefeldin A (5  μ g/ml; 
Sigma-Aldrich). Negative controls were obtained in the absence of peptide 
and prestaining with pentamer/tetramer. Cytofi x/Cytoperm (BD Biosciences) 
was used for permeabilization of the cells before staining for intracellular 
markers. For in vitro expansion, 10 5 PBMCs per well were cultivated in RPMI 
1640 media supplemented with 8% heat-inactivated human serum in 96-well 
round-bottom plates in the presence of 1  μ M KK10 peptide. 150 U/ml IL-2 
was added after 2 d, and fresh medium was added on day 6. Cultures were 
harvested on day 9 to be stained with pentamers and surface antibodies. 
 Clonotype analysis.  Clonotype analysis was performed on live HIV-specifi c 
CD8  T cells labeled with cognate MHC class I – peptide tetramers or pentam-
ers, and sorted using a FACSAria (BD Biosciences) in a category III laboratory. 
Between 400 and 2,000 cells were collected for each population and directly 
sorted into 1.5-ml microtubes containing 100  
 l RNAlater (Ambion). After 
cell lysis, mRNA was extracted (Oligotex kit; QIAGEN) and subjected to a 
nonnested, template-switch anchored RT-PCR using a 3  TCRB constant 
region primer, as previously described ( 25, 26 ). Amplifi ed products were li-
gated into pGEM-T Easy vector (Promega) and cloned by transformation of 
competent DH5   Escherichia coli . Selected colonies were amplifi ed by PCR 
using standard M13 primers and sequenced from an insert-specifi c primer us-
ing fl uorescent dye terminator chemistry (Applied Biosystems). A minimum of 
50 clones was generated and analyzed per sample. Pseudogenes and  “ nonfunc-
tional ” sequences that could not be resolved after inspection of the individual 
chromatograms were discarded from the analysis. Nucleotide comparisons 
were used to establish clonal identity. Data analysis was performed using 
Sequencher software (version 4.6; Gene Codes). The international ImMuno-
GeneTics nomenclature system is used throughout this paper ( 25, 39 ). In total, 
30 live populations were sorted to generate 1,914  TCRB sequences. 
 DNA sequencing of HIV-1  gag .  Whole cellular DNA was extracted from 
PBMC (3 – 5 millions of cells) using a QIAamp DNA blood kit (QIAGEN), 
according to the manufacturer ’ s recommendations. First-round PCR was 
conducted to amplify the Gag region (nt 734 – 2,047) with the following 
primer pair: (forward) 5  -GACTGGTGAGTACGCCAAAA-3  (GAG1) and 
(reverse) 5  -CTTCCTTTCCACATTTCCAACAGC-3  (GAG2). Then, a 
second-round PCR (nt 812 – 1,920) was performed using the following 
primer pair: (forward) 5  -AAGCGGGGGAGAATTAGAT-3  (GAG3) and 
(reverse) 5  -CATTATGGTAGCTGAAAT-3  (GAG5). The PCR product 
was purifi ed with Amicon ’ s Microcon 100 (Millipore). The Gag region was 
sequenced (aa 20 – 363) using a cycle-sequencing reaction with the Big Dye 
terminator kit (Applied Biosystems) using the GAG3 and GAG5 primers. 
The sequences were aligned on the HXB2 reference sequence using Sequence 
Navigator software (Applied Biosystems). 
 Statistics.  Group medians and distributions were compared by the Mann-
Whitney U test, the permutation test, or the paired  t test. Associations 
between variables were determined by the nonparametric Spearman correlation 
test. P   0.05 was considered not signifi cant. 
 Online supplemental material.  Table S1 shows  TCRB sequences from 
all FACS-sorted HIV-specifi c CD8  T cell populations ( n  30) studied 
(representing a total of 1,914 sequences). Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20070784/DC1. 
was performed by amplifi cation refractory mutation system – PCR using 
sequence-specifi c primers, as previously described ( 50 ). HLA-genotyped 
patients were screened for HIV-specifi c CD8  T cell responses with IFN-  
ELISPOT assays using a panel of 49 known HLA class I – restricted viral 
epitope peptides. The 11 HLA-B27 patients studied were subtyped, and all 
were found to carry the HLA-B∗2705 allele. 
 Quantifi cation of cVL.  HIV-1 cVL was quantifi ed in PBMCs using a real-
time PCR assay combining the quantifi cation of HIV-1 cVL and albumin 
gene DNA. This assay allows the detection of fi ve copies of HIV-1 cVL in 
10 6 PBMCs ( 13 ). This was performed with fl uorescent TaqMan methodol-
ogy on a sequence detection system (ABI Prism 7700; Applied Biosystems). 
 CD8  T cell epitopes and IFN-  ELISPOT assay.  Synthetic 15-mer 
peptides overlapping by 11 aa and spanning the entire HIV-1 Gag sequence 
were purchased from Neosystem and pooled into 11 – 15 peptide pools: 5 p24 
pools, 3 p17 pools, and 3 PP (i.e., p2/p7/p1/p6) pools. In addition, 
49 CD8  T cell epitopes, 8 – 11 aa in length, derived from HXB2 Gag, Pol, 
Env, or Nef proteins were selected from the Los Alamos HIV molecular 
immunology database, according to the patients ’ HLA class I haplotypes, and 
synthesized by Syntem, or provided by ANRS. All peptides used in this study 
were   80% purity, as shown by HPLC profi les. For the ELISPOT assays, 
thawed PBMCs were plated at 10 5 cells per well in 96-well polyvinylidene 
plates (Millipore) precoated with capture anti – human IFN-  mAb (Dia-
clone) at 4 ° C overnight. The fi nal peptide concentration in screening assays 
was 2  μ g/ml for overlapping peptides or 10  μ M for optimal CTL epitopes. 
Plates were incubated overnight at 37 ° C/5% CO 2 and developed according 
to the manufacturer ’ s recommendations. Spots were counted using an auto-
mated ELISPOT reader (Carl Zeiss MicroImaging, Inc.), and data were ex-
pressed as spot-forming units (SFU) per 10 6 PBMCs. Results were considered 
positive if   50 SFU/10 6 PBMCs were stained after subtraction of the mean 
background obtained with cells alone. Functional avidity, which in this study 
refers to activation threshold in response to defi ned concentrations of exoge-
nous peptide, was assessed by performing limiting peptide dilutions (from 
100 to 0.001  μ M) and determining the peptide concentration required to in-
duce half-maximum IFN-  production (number of spots) in ex vivo assays. 
Results were considered appropriate for analysis only when maximum IFN-  
production was   500 SFU/10 6 PBMCs (background subtracted) for both 
immunodominant or the highest subdominant responses. 
 Flow cytometry and reagents.  HLA-A∗0301 QK10, HLA-A∗0301 
RY10, HLA-B∗0702 GL9, and HLA-B∗2705 KK10 pentamers were purchased 
from ProImmune; HLA-A∗0201 SL9 tetramer was purchased from Beckman 
Coulter; and HLA-B∗0801 FL9 tetramer was synthesized as previously de-
scribed ( 51 ). PBMCs were stained with pretitrated concentrations of pen-
tamer/tetramer (conjugated to PE or allophycocyanin [APC]) followed by a 
panel of antibodies, as previously described ( 52 ). Directly conjugated and un-
conjugated antibodies were as follows: CD3 (Cy5.5PerCP or Alexa Fluor 
700), CD38 (APC), CD45RA (FITC), CCR7 (PE-Cy7), CD107a (Cy5-
PE), IL-2 (APC), IFN-  (Alexa Fluor 700), CD57 (FITC), and TNF-  (PE-
Cy7; all from BD Biosciences); CD28 (PE – Texas red), CD45RA (PE – Texas 
red), TCRBV mAbs (5.1, 6.6, 9, 14, 13, and 20.1 conjugated to FITC or PE; 
all from Beckman Coulter); CD8 (Alexa Fluor 405), swine anti – goat (FITC), 
and granzyme B (PE – Texas red; all from Caltag); CD127 (purifi ed) and 
MIP-1  (FITC; both from R & D Systems); PD-1 (PE; eBioscience); goat 
anti – mouse (PE; DakoCytomation); and CD27 (Alexa Fluor 700; BioLeg-
end). Anti-CD57 (Qdot-545) and anti–PD-1 (PE) antibodies were provided by 
P. Chattopadhyay (Vaccine Research Center, Bethesda, MD) and G. Freeman 
(Dana-Farber Cancer Institute, Boston, MA), respectively. Cells were ana-
lyzed on a standard LSRII (equipped with blue, red, and violet lasers; BD 
Biosciences) to systematically perform eight to nine color stainings. The list 
mode data fi les were analyzed using FlowJo software (version 8.2; TreeStar, 
Inc.) and FACSDiva software (BD Biosciences). Multifunctional data were ana-
lyzed with PESTLE software (version 1.3.2) and SPICE software (version 3.1; 
obtained from M. Roederer, National Institutes of Health, Bethesda MD). 
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